TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2020

Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study.

Aurelien Marabelle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.